Jude Onyia
Chief Tech/Sci/R&D Officer presso NEUROCRINE BIOSCIENCES, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Jude Onyia is currently the Director at Voyager Therapeutics, Inc. and the Chief Scientific Officer at Neurocrine Biosciences, Inc. Prior to his current roles, he worked at Eli Lilly & Co. for 26 years, where he held the position of Vice President-Biotechnology Discovery Research from 2014 to 2021.
He also briefly served as the Chief Scientific Officer at Capsida Biotherapeutics, Inc. in 2021.
Onyia received his undergraduate degree from The State University of New York and his doctorate from the State University of New York at Downstate Medical Center.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 13/02/2024 | 13 128 ( 0.01% ) | 2 M $ | 31/03/2024 | |
| 06/06/2023 | 2 910 ( 0.01% ) | 27 092 $ | 31/03/2024 |
Posizioni attive di Jude Onyia
| Società | Posizione | Inizio |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30/11/2021 |
| VOYAGER THERAPEUTICS, INC. | Director/Board Member | 21/02/2023 |
Precedenti posizioni note di Jude Onyia
| Società | Posizione | Fine |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Chief Tech/Sci/R&D Officer | 01/11/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2021 |
Formazione di Jude Onyia
| The State University of New York | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
- Borsa valori
- Insiders
- Jude Onyia
